Pricing mechanics · Tirzepatide
Prepaid plans: what the discount really costs
Nearly every discount in this market is attached to a term. The twelve-month rates are genuinely lower, and they are also the least reversible decision available on a medication a meaningful number of people stop taking within the first few months.
What prepaying actually saves
Among rankable tirzepatide programs publishing both a month-to-month and a twelve-month rate:
- TMates — $297 month-to-month against $167 on the twelve-month term, a 44% reduction worth $1,560 across the year.
- bmiMD — $179 month-to-month against $139 on the twelve-month term, a 22% reduction worth $480 across the year.
- NexLife — $169 month-to-month against $139 on the twelve-month term, a 18% reduction worth $360 across the year.
- HealthRX — $209 month-to-month against $179 on the twelve-month term, a 14% reduction worth $360 across the year.
- Luvo Health — $339 month-to-month against $291 on the twelve-month term, a 14% reduction worth $576 across the year.
What you are actually buying
A prepaid year is a bet that three things hold: that you tolerate the medication, that it works for you, and that the program continues to operate and ship. The discount is the price of taking all three risks off the company's balance sheet and onto yours.
The tolerability question is the sharpest of the three. Gastrointestinal side effects are common at the start, and some people stop. Committing twelve months of payment before knowing which group you are in is a real risk, not a theoretical one — and it is why the sensible sequence is usually to start month-to-month, get through titration, and convert to a term once you know the drug suits you.
Read the refund policy first
A prepaid discount and a restrictive refund policy are the same decision viewed from two directions. Before committing, establish in writing what happens if you stop at month three: is the balance refunded, credited, or forfeited, and is there a cancellation window at all. Programs vary enormously here, and the answer is rarely on the pricing page.
Our head-to-head pages compare cancellation terms directly against twelve-month figures for exactly this reason, and every provider record prints the cancellation terms we could find.
The operator risk nobody prices
The compounded GLP-1 market has been regulatorily unstable since the shortages were resolved. A prepaid year with a program whose supply lane closes is a claim against a company rather than a medication in your fridge. This is not a prediction about any specific provider — it is a reason that the correct discount for prepaying in an unstable market is larger than the correct discount in a stable one.
Questions
Is it cheaper to prepay for a year of tirzepatide?
Yes, materially. The largest published reduction in this database is 44% — TMates at $167 a month on a twelve-month term against $297 month-to-month.
What is the risk of prepaying for a GLP-1?
That you stop before the term ends — through side effects, non-response, or a change in circumstances — and cannot recover the balance. Establish the refund policy in writing before committing.
Should I start on a monthly or annual plan?
Most people are better served starting month-to-month, getting through titration, and converting to a term once tolerability is established. The discount is still there later; the risk is largest at the start.